Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan S Jaffe

Showing results (191-200 of 400) with videos related to

Pageof 40
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 19, 2014
Below normal pre-procedural cardiac troponin I levels are associated with an adverse prognosis after percutaneous coronary interventionsAlessandro Lupi, Andrea Rognoni, Maurizio Lazzero, et al.
Plos One|December 18, 2020
Influence of primary payer status on the management and outcomes of ST-segment elevation myocardial infarction in the United StatesSaraschandra Vallabhajosyula, Vinayak Kumar, Pranathi R Sundaragiri, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 20, 2016
Intracoronary Bivalirudin Bolus in ST-Elevation Myocardial Infarction Patients Treated with Primary Angioplasty: Theoretical Bases, Clinical Experience, and Future ApplicationsAlessandro Lupi, Alon Schaffer, Andrea Rognoni, et al.
JACC. Advances|March 21, 2026
Prevalence and Prognostic Implications of Atherosclerotic Coronary Artery Disease in Type 2 Myocardial InfarctionJonathan D Knott, Laura De Michieli, Olatunde Ola, et al.
Preventive Cardiology|July 20, 2006
Lipoprotein-associated phospholipase A2: review and recommendation of a clinical cut point for adultsRichard B Lanman, Robert L Wolfert, James K Fleming, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 28, 2009
Screening for kidney disease in vascular patients: SCreening for Occult REnal Disease (SCORED) experienceHeejung Bang, Madhu Mazumdar, George Newman, et al.
Circulation|June 27, 2007
Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over timeWayne L Miller, Karen A Hartman, Mary F Burritt, et al.
Cardiovascular Diabetology|September 17, 2010
Determinants and prognostic implications of cardiac troponin T measured by a sensitive assay in type 2 diabetes mellitusJonas Hallén, Odd Erik Johansen, Kåre I Birkeland, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 16, 2009
Role for precursor Pro-B type natriuretic peptide in assessing response to therapy and prognosis in patients with decompensated heart failure treated with nesiritideWayne L Miller, John C Burnett, Karen A Hartman, et al.
Journal of the American College of Cardiology|April 19, 2023
Exercise Capacity, NT-proBNP, and Exercise Hemodynamics in Adults Post-FontanWilliam R Miranda, C Charles Jain, Barry A Borlaug, et al.
Pageof 40

Showing results (191-200 of 400) with videos related to

Sort By:
Pageof 40
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 19, 2014
Below normal pre-procedural cardiac troponin I levels are associated with an adverse prognosis after percutaneous coronary interventionsAlessandro Lupi, Andrea Rognoni, Maurizio Lazzero, et al.
Plos One|December 18, 2020
Influence of primary payer status on the management and outcomes of ST-segment elevation myocardial infarction in the United StatesSaraschandra Vallabhajosyula, Vinayak Kumar, Pranathi R Sundaragiri, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 20, 2016
Intracoronary Bivalirudin Bolus in ST-Elevation Myocardial Infarction Patients Treated with Primary Angioplasty: Theoretical Bases, Clinical Experience, and Future ApplicationsAlessandro Lupi, Alon Schaffer, Andrea Rognoni, et al.
JACC. Advances|March 21, 2026
Prevalence and Prognostic Implications of Atherosclerotic Coronary Artery Disease in Type 2 Myocardial InfarctionJonathan D Knott, Laura De Michieli, Olatunde Ola, et al.
Preventive Cardiology|July 20, 2006
Lipoprotein-associated phospholipase A2: review and recommendation of a clinical cut point for adultsRichard B Lanman, Robert L Wolfert, James K Fleming, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 28, 2009
Screening for kidney disease in vascular patients: SCreening for Occult REnal Disease (SCORED) experienceHeejung Bang, Madhu Mazumdar, George Newman, et al.
Circulation|June 27, 2007
Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over timeWayne L Miller, Karen A Hartman, Mary F Burritt, et al.
Cardiovascular Diabetology|September 17, 2010
Determinants and prognostic implications of cardiac troponin T measured by a sensitive assay in type 2 diabetes mellitusJonas Hallén, Odd Erik Johansen, Kåre I Birkeland, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 16, 2009
Role for precursor Pro-B type natriuretic peptide in assessing response to therapy and prognosis in patients with decompensated heart failure treated with nesiritideWayne L Miller, John C Burnett, Karen A Hartman, et al.
Journal of the American College of Cardiology|April 19, 2023
Exercise Capacity, NT-proBNP, and Exercise Hemodynamics in Adults Post-FontanWilliam R Miranda, C Charles Jain, Barry A Borlaug, et al.
Pageof 40